Market Whales and Their Recent Bets on LLY Options
Market Whales and Their Recent Bets on LLY Options
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Eli Lilly's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Eli Lilly's substantial trades, within a strike price spectrum from $500.0 to $1440.0 over the preceding 30 days.Financial giants have made a conspicuous bullish move on Eli Lilly. Our analysis of options history for Eli Lilly (NYSE:LLY) revealed 13 unusual trades.
金融巨頭在Eli Lilly上做出引人注目的看好舉動。我們對Eli Lilly（紐約證券交易所：LLY）的期權歷史進行分析，發現了13筆異常交易。
Delving into the details, we found 53% of traders were bullish, while 15% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $190,238, and 11 were calls, valued at $638,091.
深入細節，我們發現53%的交易員持有看好態度，而15%表現出看淡的傾向。在我們發現的所有交易中，有2筆看跌交易，價值190,238美元，有11筆看漲交易，價值638,091美元。
Predicted Price Range
預測價格區間
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $500.0 to $1440.0 for Eli Lilly over the recent three months.
根據交易活動，顯然一些重要投資者正瞄準Eli Lilly在最近三個月的價格區間從$500.0到$1440.0。
Insights into Volume & Open Interest
成交量和持倉量分析
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Eli Lilly's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Eli Lilly's substantial trades, within a strike price spectrum from $500.0 to $1440.0 over the preceding 30 days.
評估成交量和未平倉合約是期權交易中的一項戰略步驟。這些指標揭示了Eli Lilly期權在指定行權價上的流動性和投資者興趣。即將到來的數據將可視化呈現出過去30天內與Eli Lilly的重要交易相關的看湧量和未平倉合約的波動，這些交易均在$500.0至$1440.0的行權價範圍內。
Eli Lilly Option Volume And Open Interest Over Last 30 Days
Eli Lilly過去30天的期權成交量和未平倉合約量
Noteworthy Options Activity:
值得注意的期權活動：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | CALL | SWEEP | BULLISH | 02/21/25 | $22.9 | $21.6 | $22.9 | $880.00 | $160.3K | 189 | 105 |
| LLY | PUT | TRADE | NEUTRAL | 11/08/24 | $26.2 | $24.3 | $25.31 | $810.00 | $146.7K | 636 | 61 |
| LLY | CALL | TRADE | BULLISH | 02/21/25 | $59.5 | $59.5 | $59.5 | $780.00 | $119.0K | 131 | 43 |
| LLY | CALL | TRADE | BEARISH | 12/18/26 | $22.85 | $21.6 | $21.6 | $1440.00 | $62.6K | 44 | 30 |
| LLY | CALL | TRADE | BULLISH | 06/20/25 | $300.5 | $296.1 | $300.5 | $500.00 | $60.1K | 4 | 2 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | 看漲 | 飛凡 | 看好 | 02/21/25 | $22.9 | $21.6 | $22.9 | $880.00 | $160.3K | $ | 105 |
| LLY | 看跌 | 交易 | 中立 | 11/08/24 | $26.2 | $24.3 | $25.31 | 810.00美元 | $146.7K | 636 | 61 |
| LLY | 看漲 | 交易 | 看好 | 02/21/25 | $59.5 | $59.5 | $59.5 | $780.00 | $119.0K | 131 | 43 |
| LLY | 看漲 | 交易 | 看淡 | 12/18/26 | $22.85 | $21.6 | $21.6 | $1440.00 | $62.6K | 44 | 30 |
| LLY | 看漲 | 交易 | 看好 | 06/20/25 | $300.5 | $296.1 | $300.5 | $500.00 | $60.1K | 4 | 2 |
About Eli Lilly
關於Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Eli Lilly是一家專注於神經科學，心臟代謝，癌症和免疫學的藥物公司。Lilly的主要產品包括用於治療癌症的Verzenio；用於心臟代謝的Mounjaro，Zepbound，Jardiance，Trulicity，Humalog和Humulin；以及用於免疫學的Taltz和Olumiant。
After a thorough review of the options trading surrounding Eli Lilly, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
經過對以往與Eli Lilly有關的期權交易的徹底審查，我們轉而更詳細地研究這家公司。這包括對其當前市場地位和表現的評估。
Current Position of Eli Lilly
Eli Lilly的當前位置
- With a volume of 648,226, the price of LLY is up 1.08% at $784.78.
- RSI indicators hint that the underlying stock may be oversold.
- Next earnings are expected to be released in 89 days.
- 以648,226的成交量，LLY的價格上漲1.08%，報784.78美元。
- RSI指標表明該基礎股票可能被超賣。
- 下一次業績預計在89天后發佈。
What Analysts Are Saying About Eli Lilly
分析師對Eli Lilly的看法
5 market experts have recently issued ratings for this stock, with a consensus target price of $1074.6.
最近有5位市場專家爲這支股票發佈了評級，一致的目標價是1074.6美元。
Turn $1000 into $1270 in just 20 days?
在短短20天內，將1000美元變成1270美元？
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access.* Consistent in their evaluation, an analyst from Truist Securities keeps a Buy rating on Eli Lilly with a target price of $1033. * An analyst from Citigroup persists with their Buy rating on Eli Lilly, maintaining a target price of $1250. * An analyst from Deutsche Bank has decided to maintain their Buy rating on Eli Lilly, which currently sits at a price target of $1015. * An analyst from Barclays persists with their Overweight rating on Eli Lilly, maintaining a target price of $975. * An analyst from B of A Securities has decided to maintain their Buy rating on Eli Lilly, which currently sits at a price target of $1100.
20年期權交易專家透露了他的一線圖表技術，顯示何時買入和賣出。複製他的交易，平均每20天獲利27%。點擊這裏獲取訪問。* Truist Securities的一位分析師堅持給Eli Lilly股票買入評級，目標價爲1033美元。* Citigroup的一位分析師堅持給Eli Lilly股票買入評級，目標價爲1250美元。* 德意志銀行的一位分析師決定維持給Eli Lilly股票買入評級，目前的目標價爲1015美元。* 巴克萊銀行的一位分析師堅持給Eli Lilly股票超配評級，目標價爲975美元。* b of A Securities的一位分析師決定維持給Eli Lilly股票買入評級，目前的目標價爲1100美元。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Eli Lilly with Benzinga Pro for real-time alerts.
期權交易涉及更大的風險，但也提供更高利潤的潛力。精明的交易員通過持續教育、戰略交易調整、利用各種因子，並保持對市場動態的敏感，來減輕這些風險。通過Benzinga Pro及時了解Eli Lilly的最新期權交易，獲取實時警報。
譯文內容由第三人軟體翻譯。
